Encompass Health Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Encompass Health stock have an average target of 143.29, with a low estimate of 125 and a high estimate of 160. The average target predicts an increase of 32.66% from the current stock price of 108.01.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$125	$143.29	$140	$160
Change	+15.73%	+32.66%	+29.62%	+48.13%

Analyst Ratings

The average analyst rating for Encompass Health stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	3	3	3	3	3
Buy	3	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Mok Barclays	Barclays	Buy Maintains $150 → $153	Buy	Maintains	$150 → $153	+41.65%	Feb 6, 2026
Andrew Mok Barclays	Barclays	Buy Maintains $141 → $150	Buy	Maintains	$141 → $150	+38.88%	Oct 30, 2025
A.J. Rice UBS	UBS	Strong Buy Maintains $140 → $150	Strong Buy	Maintains	$140 → $150	+38.88%	Oct 2, 2025
Matthew Gillmor Keybanc	Keybanc	Buy Maintains $135 → $140	Buy	Maintains	$135 → $140	+29.62%	Sep 16, 2025
Kevin Fischbeck B of A Securities	B of A Securities	Strong Buy Maintains $145 → $160	Strong Buy	Maintains	$145 → $160	+48.13%	Sep 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.49B

from 5.94B

9.38%

from 5.94B

Revenue Next Year

7.02B

from 6.49B

8.12%

from 6.49B

EPS This Year

5.87

from 5.54

5.93%

from 5.54

EPS Next Year

6.37

from 5.87

8.56%

from 5.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	4.01B	4.35B	4.80B	5.37B	5.94B	6.49B	7.02B
Revenue Growth	12.58%	8.31%	10.41%	11.91%	10.46%	9.38%	8.12%
EPS	4.11	2.70	3.47	4.46	5.54	5.87	6.37
EPS Growth	44.46%	-34.39%	28.74%	28.32%	24.25%	5.93%	8.56%
Forward PE	-	-	-	-	-	18.40	16.95
No. Analysts	-	-	-	-	-	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	6.8B	7.4B
Avg	6.5B	7.0B
Low	6.3B	6.8B

Revenue Growth

Revenue Growth	2026	2027
High	14.2%	14.0%
Avg	9.4%	8.1%
Low	5.9%	4.2%

EPS Forecast

EPS	2026	2027
High	6.52	7.13
Avg	5.87	6.37
Low	5.33	5.77

EPS Growth

EPS Growth	2026	2027
High	17.7%	21.5%
Avg	5.9%	8.6%
Low	-3.8%	-1.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.